Evidence map›Paper›PMID 38798407›Full record

ArticlebioRxiv : the preprint server for biology2024

An epilepsy-associated CILK1 variant compromises KATNIP regulation and impairs primary cilia and Hedgehog signaling.

Ana Limerick, Ellie A McCabe, Jacob S Turner, Kevin W Kuang, David L Brautigan, Yi Hao, Cherry Chu, Sean H Fu, Sean Ahmadi, Wenhao Xu and 1 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Ana LimerickDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
Ellie A McCabeDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
Jacob S TurnerDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
Kevin W KuangDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
David L BrautiganDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.
Yi HaoDepartment of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA 22908, USA.
Cherry ChuDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
Sean H FuDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
Sean AhmadiDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
Wenhao XuDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.
Zheng FuDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Dina Gould Halme · 1987 to 2026
$72.1M
Signaling Mechanisms and Cellular Functions of a Ciliopathy-Associated Protein KinaseR01GM127690 · NIGMS · UNIVERSITY OF VIRGINIA · PI Zheng Fu · 2018 to 2026
$2.4M
NCI NIH HHS P30 CA044579NIGMS NIH HHS R01 GM127690
6 · The paper itself

Abstract

Mutations in human

Indexed as

CILK1epilepsyHedgehog signalingKATNIPprimary ciliavariant

Identifiers

PMID38798407
PMCPMC11118389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.